Beacon Pointe Advisors LLC Has $1.58 Million Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Beacon Pointe Advisors LLC reduced its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRGGet Rating) by 38.8% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 7,864 shares of the medical equipment provider’s stock after selling 4,982 shares during the quarter. Beacon Pointe Advisors LLC’s holdings in Intuitive Surgical were worth $1,576,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also modified their holdings of the company. Jennison Associates LLC increased its stake in Intuitive Surgical by 124.8% during the 1st quarter. Jennison Associates LLC now owns 5,473,854 shares of the medical equipment provider’s stock worth $1,651,352,000 after purchasing an additional 3,038,455 shares in the last quarter. Edgewood Management LLC boosted its stake in shares of Intuitive Surgical by 20.3% during the 1st quarter. Edgewood Management LLC now owns 8,902,682 shares of the medical equipment provider’s stock worth $2,685,761,000 after acquiring an additional 1,504,353 shares during the period. Vanguard Group Inc. increased its holdings in shares of Intuitive Surgical by 1.6% during the 1st quarter. Vanguard Group Inc. now owns 28,519,307 shares of the medical equipment provider’s stock worth $8,603,704,000 after acquiring an additional 457,262 shares during the last quarter. Clearbridge Investments LLC raised its stake in Intuitive Surgical by 23.1% in the 1st quarter. Clearbridge Investments LLC now owns 2,428,635 shares of the medical equipment provider’s stock valued at $732,671,000 after acquiring an additional 455,461 shares during the period. Finally, Wellington Management Group LLP boosted its position in Intuitive Surgical by 179.7% during the first quarter. Wellington Management Group LLP now owns 585,657 shares of the medical equipment provider’s stock worth $176,682,000 after purchasing an additional 376,272 shares during the period. 82.44% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several analysts recently weighed in on ISRG shares. Mizuho began coverage on Intuitive Surgical in a report on Wednesday, October 12th. They set a “neutral” rating and a $215.00 price target for the company. Piper Sandler raised their price objective on Intuitive Surgical from $260.00 to $265.00 and gave the company an “overweight” rating in a research note on Wednesday, October 19th. JPMorgan Chase & Co. raised their price objective on Intuitive Surgical from $250.00 to $280.00 and gave the company an “overweight” rating in a report on Friday, November 18th. Barclays initiated coverage on shares of Intuitive Surgical in a research report on Monday, October 17th. They set an “overweight” rating and a $235.00 target price on the stock. Finally, Citigroup lowered their price target on shares of Intuitive Surgical from $243.00 to $237.00 in a report on Wednesday, October 5th. Eight analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $261.05.

Insider Buying and Selling

In related news, Director Amal M. Johnson sold 6,375 shares of the business’s stock in a transaction dated Tuesday, November 8th. The shares were sold at an average price of $239.36, for a total transaction of $1,525,920.00. Following the completion of the sale, the director now owns 11,224 shares of the company’s stock, valued at approximately $2,686,576.64. The sale was disclosed in a legal filing with the SEC, which is available through this link. In related news, CEO Gary S. Guthart sold 44,203 shares of the firm’s stock in a transaction that occurred on Friday, October 21st. The shares were sold at an average price of $210.84, for a total value of $9,319,760.52. Following the completion of the transaction, the chief executive officer now owns 23,297 shares of the company’s stock, valued at approximately $4,911,939.48. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Amal M. Johnson sold 6,375 shares of the firm’s stock in a transaction that occurred on Tuesday, November 8th. The stock was sold at an average price of $239.36, for a total transaction of $1,525,920.00. Following the sale, the director now owns 11,224 shares of the company’s stock, valued at $2,686,576.64. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 72,953 shares of company stock worth $15,867,996. 0.90% of the stock is currently owned by corporate insiders.

Intuitive Surgical Stock Up 0.6 %

ISRG opened at $264.45 on Thursday. Intuitive Surgical, Inc. has a 52 week low of $180.07 and a 52 week high of $369.21. The company has a market cap of $93.45 billion, a PE ratio of 69.78, a P/E/G ratio of 5.79 and a beta of 1.38. The business has a 50 day moving average price of $219.05 and a two-hundred day moving average price of $216.96.

Intuitive Surgical (NASDAQ:ISRGGet Rating) last posted its earnings results on Tuesday, October 18th. The medical equipment provider reported $1.19 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.12 by $0.07. The firm had revenue of $1.56 billion for the quarter, compared to analyst estimates of $1.52 billion. Intuitive Surgical had a return on equity of 11.54% and a net margin of 22.52%. Intuitive Surgical’s revenue was up 11.0% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.04 EPS. As a group, sell-side analysts expect that Intuitive Surgical, Inc. will post 3.79 EPS for the current fiscal year.

Intuitive Surgical Company Profile

(Get Rating)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Featured Stories

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRGGet Rating).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.